핵의학

본문글자크기
  • [Medicine (Baltimore).] Optimization of serum thyroglobulin measured at different time points for prognostic evaluation in differentiated thyroid carcinoma patients.

    전남의대 / Pupree Mutsuddy, 권성영*

  • 출처
    Medicine (Baltimore).
  • 등재일
    2020 Apr
  • 저널이슈번호
    99(14):e19652. doi: 10.1097/MD.0000000000019652.
  • 내용

    바로가기  >

    Abstract
    Although serum thyroglobulin (Tg) is a reliable differentiated thyroid carcinoma (DTC) prognostic marker, its cutoff values can be affected by TSH stimulation status. Serum Tg prognostic values measured at different time points before and after radioactive iodine (RAI) therapy prepared with recombinant human TSH (rhTSH) in DTC patients, were investigated.This study included 160 DTC patients who underwent surgery followed by rhTSH-aided RAI therapy. Their serum Tg levels were measured 7 days before (D-7Tg), on the day of (D0Tg), and 2 days after (D2Tg) the RAI therapy. For response evaluation, the patients were classified into 2 groups: acceptable response and non-acceptable response (non-AR). Optimal Tg level cutoff values measured at different time points were evaluated for persistent or recurrent disease (PRD) prediction, as well as therapeutic response.Multivariate analysis showed that D-7Tg, D0Tg, and D2Tg significantly predicted non-AR (P < .05, for all). Optimal Tg level cutoff values for non-AR prediction were 0.6, 2.6, and 3.7 ng/mL for D-7Tg, D0Tg, and D2Tg, respectively. Cox regression analysis showed that Tg levels were significantly associated with PRD free survival with D-7Tg, D0Tg, and D2Tg cutoff values of 0.8, 4.0, and 6.0 ng/mL, respectively (D-7Tg, P = .010; D0Tg, P = .005; D2Tg, P = .011).Serum Tg levels measured at the different time points could predict PRD free survival as well as therapeutic response with different cutoff values in DTC patients who underwent rhTSH-aided RAI therapy.

     


    Author information

    Mutsuddy P1,2, Jeon S1, Yoo SW1, Zhang Y1,3, Chowdhury MSA1,4, Kim J5, Song HC5,6, Bom HS1,6, Min JJ1,6, Kwon SY1,6.
    1
    Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, Jeonnam, Republic of Korea.
    2
    National Institute of Nuclear Medicine and Allied Sciences, Bangladesh Atomic Energy Commission, Dhaka, Bangladesh.
    3
    Department of Nuclear Medicine, Shandong Cancer Hospital and Institute, Jinan, China.
    4
    Institute of Nuclear Medicine and Allied Sciences, Bangladesh Atomic Energy Commission, Bogra, Bangladesh.
    5
    Department of Nuclear Medicine, Chonnam National University Hospital, Gwangju.
    6
    Department of Nuclear Medicine, Chonnam National University Medical School, Jeonnam, Republic of Korea.

  • 덧글달기
    덧글달기
       IP : 3.138.114.38

    등록